Relationship Between Esbls Production And Virulence Factors Of Fima And Papc Gene In Uropathogenic Escherichia Coli Isolation From Private Hospital

Authors

  • Ade Hasan Basri Faculty of Medicine, Jenderal Soedirman University, Purwokerto, Central Java
  • Anang Kurniawan Faculty of Medicine, Jenderal Soedirman University, Purwokerto, Central Java
  • Joko Setyono Faculty of Medicine, Jenderal Soedirman University, Purwokerto, Central Java
  • Dwi Utami Anjarwati Faculty of Medicine, Jenderal Soedirman University, Purwokerto, Central Java

DOI:

https://doi.org/10.46799/jhs.v3i12.695

Keywords:

ESBL, fimA, papC, Escherichia coli, virulence factors

Abstract

Escherichia coli is one of the opportunistic pathogenic that occupies the highest position causing the incidence of UTI. Fimbriae, particularly type 1 and P fimbriae, are the most commonly implicated bacterial cell surface virulence factors. The production of ESBL and virulence factors in E.coli bacteria causes chronicity, persistence, and recurrence of infections that cause high morbidity and mortality. Therefore, this study was conducted to explain the relationship between ESBL production and its virulence factors in E.coli bacteria. The design of this research is analytically observational with a cross-sectional approach conducted from March to May 2021. A total of 40 E. coli strains were isolated and collected from urine samples of UTI patients who were admitted to the hospital. in a private Hospital in Banyumas Region in Central Java, Indonesia. The HiChrome ESBL Agar Base media was used to screen for ESBL-Producing E. coli. Identification of firmA and papC genes was performed by using the PCR method. All urine samples diagnosed with UTI were examined for ESBL production. As many as 25% of E.coli were ESBL-production. All isolates showing positive E.coli ESBL results were then analyzed for fimA and papC genes using the PCR method. The results obtained 100% fimA gene and 80% papC gene. The conclusion is that there is a strong relationship between ESBL production with fimA and papC genes.

References

Al-Amiery, A. A., Binti Kassim, F. A., Kadhum, A. A. H., & Mohamad, A. B. (2016). Synthesis and characterization of a novel eco-friendly corrosion inhibition for mild steel in 1 M hydrochloric acid. Scientific Reports, 6(1), 1–13.

Andersen, S., Nawrocki, A., Johansen, A. E., Herrero-Fresno, A., Menéndez, V. G., Møller-Jensen, J., & Olsen, J. E. (2022). Proteomes of Uropathogenic Escherichia coli Growing in Human Urine and in J82 Urinary Bladder Cells. Proteomes, 10(2), 15.

Bien, J., Sokolova, O., & Bozko, P. (2012). Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. International Journal of Nephrology, 2012.

Collinson, S. K., Emödy, L., Trust, T. J., & Kay, W. W. (1992). Thin aggregative fimbriae from diarrheagenic Escherichia coli. Journal of Bacteriology, 174(13), 4490–4495.

Connell, I., Agace, W., Klemm, P., Schembri, M., Mărild, S., & Svanborg, C. (1996). Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proceedings of the National Academy of Sciences, 93(18), 9827–9832.

Dumaru, R., Baral, R., & Shrestha, L. B. (2019). Study of biofilm formation and antibiotic resistance pattern of gram-negative Bacilli among the clinical isolates at BPKIHS, Dharan. BMC Research Notes, 12(1), 1–6.

Emody, L., Kerenyi, M., & Nagy, G. (2003). Virulence factors of uropathogenic Escherichia coli. International Journal of Antimicrobial Agents, 22, 29–33.

Fattahi, S., Kafil, H. S., Nahai, M. R., Asgharzadeh, M., Nori, R., & Aghazadeh, M. (2015). Relationship of biofilm formation and different virulence genes in uropathogenic Escherichia coli isolates from Northwest Iran. GMS Hygiene and Infection Control, 10.

Grohs, P., Tillecovidin, B., Caumont-Prim, A., Carbonnelle, E., Day, N., Podglajen, I., & Gutmann, L. (2013). Comparison of five media for detection of extended-spectrum Beta-lactamase by use of the wasp instrument for automated specimen processing. Journal of Clinical Microbiology, 51(8), 2713–2716.

Heffernan, H. M., Woodhouse, R. E., Pope, C. E., & Blackmore, T. K. (2009). Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. International Journal of Antimicrobial Agents, 34(6), 544–549.

Katongole, P., Nalubega, F., Florence, N. C., Asiimwe, B., & Andia, I. (2020). Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda. BMC Infectious Diseases, 20(1), 1–6.

Klemm, P., & Schembri, M. A. (2000). Bacterial adhesins: function and structure. International Journal of Medical Microbiology, 290(1), 27–35.

Köhler, C.-D., & Dobrindt, U. (2011). What defines extraintestinal pathogenic Escherichia coli? International Journal of Medical Microbiology, 301(8), 642–647.

Neupane, S., Pant, N. D., Khatiwada, S., Chaudhary, R., & Banjara, M. R. (2016). Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal. Antimicrobial Resistance and Infection Control, 5(1), 1–5.

Parvez, S. A., & Rahman, D. (2018). Virulence Factors of Uropathogenic E. coli. Microbiology of Urinary Tract Infections-Microbial Agents and Predisposing Factors, 7–21.

Prasetya, Y. A., Nisya, K., & Amanda, E. R. (2019). Aktivitas Nanoemulsi Minyak Lengkuas (Alpinia galanga [L] Willd) Dalam Menghambat Bakteri Escherichia coli Penghasil Extended Spectrum Beta Lactamases (ESBLs).

Riegman, N., Van Die, I., Leunissen, J., Hoekstra, W., & Bergmans, H. (1988). Biogenesis of F71 and F72 fimbriae of uropathogenic Escherichia coli: influence of the FsoF and FstFG proteins and localization of the Fso/FstE protein. Molecular Microbiology, 2(1), 73–80.

Shah, C., Baral, R., Bartaula, B., & Shrestha, L. B. (2019). Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance. BMC Microbiology, 19(1), 1–6.

Shrestha, R., Khanal, S., Poudel, P., Khadayat, K., Ghaju, S., Bhandari, A., Lekhak, S., Pant, N. D., Sharma, M., & Marasini, B. P. (2019). Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal. Annals of Clinical Microbiology and Antimicrobials, 18(1), 1–6.

Talbot, G. H., Bradley, J., Edwards Jr, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clinical Infectious Diseases, 42(5), 657–668.

Terlizzi, M. E., Gribaudo, G., & Maffei, M. E. (2017). UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Frontiers in Microbiology, 8, 1566.

Vickers, N. J. (2017). Animal communication: when i’m calling you, will you answer too? Current Biology, 27(14), R713–R715.

Vigil, P. D., Alteri, C. J., & Mobley, H. L. T. (2011). Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence. Infection and Immunity, 79(6), 2335–2344.

Winberg, J. (1984). P-fimbriae, bacterial adhesion, and pyelonephritis. Archives of Disease in Childhood, 59(2), 180.

Wullt, B., Bergsten, G., Connell, H., Röllano, P., Gebretsadik, N., Hull, R., & Svanborg, C. (2000). P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Molecular Microbiology, 38(3), 456–464.

Zamani, H., & Salehzadeh, A. (2018). Biofilm formation in uropathogenic Escherichia coli: Association with adhesion factor genes. Turkish Journal of Medical Sciences, 48(1), 162–167. https://doi.org/10.3906/sag-1707-3

Downloads

Published

2022-12-13

Issue

Vol. 3 No. 12 (2022): Jurnal Health Sains

Section

Articles

License

Copyright (c) 2022 Ade Hasan Basri, Anang Kurniawan, Joko Setyono, Dwi Utami Anjarwati

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.